Ferdinandus, Justin http://orcid.org/0000-0002-3481-7997
Zaremba, Anne
Zimmer, Lisa
Umutlu, Lale
Seifert, Robert
Barbato, Francesco
Ugurel, Selma
Chorti, Eleftheria
Grünwald, Viktor
Herrmann, Ken
Schadendorf, Dirk
Fendler, Wolfgang Peter
Livingstone, Elisabeth
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 10 September 2021
Accepted: 18 January 2022
First Online: 5 February 2022
Declarations
:
: This analysis was approved by the local ethics committee (Reference: 20–9433-BO).
: Not required
: JF has received fees from Eisai, outside of the submitted work. AZ received travel support from Novartis, Sanofi Genzyme, and Bristol-Myers Squibb, outside the submitted work. LZ received honoraria from Roche, BMS, MSD, Novartis, Pierre Fabre; Consultant or Advisory Role: BMS, Novartis, Pierre Fabre, Sunpharma, Sanofi, MSD; Research funding to institution: Novartis; Travel support: BMS, Pierre Fabre, Sanofi, Amgen, Novartis, Sunpharma. LU reports Speaker for Bayer Healthcare; Speaker and Research Grant Siemens Healtcare outside of the submitted work. VG reports grants, personal fees and non-financial support from Astra Zeneca, Bristol-Myers Squibb, MSD Sharp & Dohme, Ipsen, Pfizer. Personal fees from Merck Serono, EUSAPharm, Novartis, Eisai, Bayer, Roche, Janssen-Cilag, Lilly and PharmaMar. SU declares research support from Bristol Myers Squibb and Merck Serono; speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, Novartis and Roche, and travel support from Bristol Myers Squibb, and Merck Sharp & Dohme. EC received travel support from Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis, outside the submitted work. DS reports personal fees and non-financial support from Roche/Genentech, grants, personal fees, non-financial support and other from BMS, personal fees from Merck Sharp & Dohme, personal fees and non-financial support from Merck Serono, grant, personal fees and non-financial support from Amgen, personal fees from Immunocore, personal fees from Incyte, personal fees from 4SC, personal fees from Pierre Fabre, personal fees and non-financial support from Sanofi/Regeneron, personal fees from Array BioPharma, personal fees from Pfizer, personal fees from Philogen, personal fees from Regeneron, personal fees from Nektar, personal fees from Sandoz, grants, personal fees and non-financial support from Novartis, personal fees and non-financial support from SunPharma, Replimune, Helsinn, OncoSec and InFlaRx outside the submitted work. WPF is a consultant for BTG, and he received fees from RadioMedix, Bayer, and Parexel outside of the submitted work. EL served as consultant and/or has received honoraria from Amgen, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Medac, Sanofi, Sunpharma and travel support from Amgen, Merck Sharp & Dohme, Bristol-Myers Squibb, Pierre Fabre, Sunpharma and Novartis, outside the submitted work. All others have nothing to disclose.